Mycophenolate mofetil Completed Phase 4 Trials for De Novo Renal Transplant Recipient Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00166244Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation